Clinical Outcomes of  Eyedeal’s PA60AS1 Monofocal Intraocular Lens

From 2019 to 2021, Xi’an Eyedeal Medical Technology Co., Ltd. conducted a…


Eyedeal Completes RMB 100 Million Series B Financing to Accelerate Product Commercialization

Recently, Xi’an Eyedeal Medical Technology Co., Ltd. announced the successful…


Eyedeal Completes Enrollment for First Toric Intraocular Lens Clinical Trial in China

On April 18, Xi’an Eyedeal Medical Technology Co., Ltd. announced the…


Eyedeal Selected for KPMG China’s Second Annual “Biotech Innovation 50” List

On April 7, the KPMG China 2nd Biotech Innovation 50 Awards Ceremony was held…


Eyedeal’s Premium Foldable Intraocular Lens Approved for Market Launch

Recently, the National Medical Products Administration (NMPA) announced the…